Bristol-Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, haematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.
Bristol-Myers Squibb has been in operation in Ireland since 1964, employing over 600 people across a range of activities and business units. Many of the global business services, including the European Treasury Centre, Global Biologics Release Laboratory and Global Logistics are based on the island of Ireland.
Located in Dublin, Cruiserath Biologics Campus, a one billion Multi-Product Cell Culture Biologics Manufacturing facility, is part of the Global Product Development and Supply (GPS) network. This state of the art facility produces multiple therapies for the company’s growing biologics portfolio and plays a central role in Bristol-Myers Squibb global manufacturing network. Global Biologics Release Laboratory is responsible for the release testing of Biologics Drug product for the network, it is also based on the Cruiserath Biologics Campus.
Ireland is also home to External manufacturing’s global headquarters, the business unit responsible for the management of manufacturing contract operations (CMO’s) and ensuring reliable supply of product to patients across the Bristol-Myers Squibb global network.
Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol-Myers Squibb company and Juno Therapeutics, a Bristol-Myers Squibb company.
For more information about Bristol-Myers Squibb, visit us at BMS.com/ie